Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Justyna Klos-Rola, Maria Tulidowicz-Bielak & Tomasz Zarnowski. (2013) Effects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case series. Clinical Ophthalmology 7, pages 1929-1935.
Read now
Read now
Volkan Hurmeric, Pravin Vaddavalli, Anat Galor, Victor L Perez, Janika San Roman & Sonia H Yoo. (2013) Single and multiple injections of subconjunctival ranibizumab for early, recurrent pterygium. Clinical Ophthalmology 7, pages 467-473.
Read now
Read now
Articles from other publishers (49)
Eunyu Yoon, Minji Park & Jaewon Choi. (2023) Effects of Subconjunctival Bevacizumab Injection after Primary Pterygium Surgery. Journal of the Korean Ophthalmological Society 64:8, pages 688-693.
Crossref
Crossref
Bowen Zhang, Xingmei Dong & Yi Sun. (2023) Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium. Frontiers in Medicine 10.
Crossref
Crossref
梦欣 贺. (2023) Pathogenesis and Advances in the Clinical Management of Pterygium. Advances in Clinical Medicine 13:11, pages 18209-18216.
Crossref
Crossref
Sanaz Sadig Baheran, Raid G. Alany, Sianne Schwikkard, Wisam Muen, Lena Namaan Salman, Nicholas Freestone & Ali A. Al-Kinani. (2023) Pharmacological treatment strategies of pterygium: Drugs, biologics, and novel natural products. Drug Discovery Today 28:1, pages 103416.
Crossref
Crossref
Brendon W.H. Lee, Amitouj S. Sidhu, Ian C. Francis & Minas T. Coroneo. (2022) 5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite. The Ocular Surface 26, pages 128-141.
Crossref
Crossref
Leila Ghiasian, Bijan Samavat, Yasaman Hadi, Mona Arbab & Navid Abolfathzadeh. (2021) Recurrent pterygium: A review. Journal of Current Ophthalmology 33:4, pages 367.
Crossref
Crossref
Li-Juan Xu, Shi-Song Rong, Ye-Sheng Xu, Li-Bin Zheng, Wen-Ya Qiu, Xia Zhang, Lou-Jing Jiang, Run-Ping Duan, Tian Tian & Yu-Feng Yao. (2020) Anti-fibrosis potential of pirarubicin via inducing apoptotic and autophagic cell death in rabbit conjunctiva. Experimental Eye Research 200, pages 108215.
Crossref
Crossref
Hee Kyung Yang, Yun Ji Lee, Joon Young Hyon, Kwang Gi Kim & Sang Beom Han. (2020) Efficacy of bevacizumab injection after pterygium excision and limbal conjunctival autograft with limbal fixation suture. Graefe's Archive for Clinical and Experimental Ophthalmology 258:7, pages 1451-1457.
Crossref
Crossref
Wai Kit Chu, Hiu Lam Choi, Amar K. Bhat & Vishal Jhanji. (2020) Pterygium: new insights. Eye 34:6, pages 1047-1050.
Crossref
Crossref
Enrique O. Graue-HernandezAndrea CórdobaAida Jimenez-CoronaArturo Ramirez-MirandaAlejandro NavasJuan C. Serna-Ojeda & Mark J. Mannis. (2019) Practice Patterns in the Management of Primary Pterygium: A Survey Study. Cornea 38:11, pages 1339-1344.
Crossref
Crossref
Yi Sun, Bowen Zhang, Xiuhua Jia, Shiqi Ling & Juan Deng. (2018) Efficacy and Safety of Bevacizumab in the Treatment of Pterygium: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of Ophthalmology 2018, pages 1-9.
Crossref
Crossref
Mehran Zarei-Ghanavati & Hamed Ghassemi. 2018. Ocular Surface Disease. Ocular Surface Disease
307
317
.
Wen Zeng, Zengming Liu, Hanjun Dai, Ming Yan, Hong Luo, Min Ke & Xiaojun Cai. (2017) Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis. BMC Ophthalmology 17:1.
Crossref
Crossref
Linda Rose, Julia M. Byrd & Yousuf Qaseem. (2017) Subtenon Injections of Ranibizumab Arrest Growth in Early Recurrent Pterygium. Eye & Contact Lens: Science & Clinical Practice 43:6, pages 399-405.
Crossref
Crossref
Hong Kyu KimJi-Young ChoiSang Min ParkChang Rae RhoKyong Jin Cho & Sangmee Ahn Jo. (2017) Tyrosine Kinase Inhibitor, Vatalanib, Inhibits Proliferation and Migration of Human Pterygial Fibroblasts. Cornea 36:9, pages 1116-1123.
Crossref
Crossref
Dilek Hacıoğlu & Hidayet Erdöl. (2016) Developments and current approaches in the treatment of pterygium. International Ophthalmology 37:4, pages 1073-1081.
Crossref
Crossref
Reza Zarei, Masoumeh Masoumpour, Sasan Moghimi, Ghasem Fakhraei, Yadollah Eslami & Masoud Mohammadi. (2017) Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy. Journal of Current Ophthalmology 29:2, pages 85-91.
Crossref
Crossref
John A. Hovanesian, Christopher E. Starr, David T. Vroman, Francis S. Mah, Jose A.P. Gomes, Marjan Farid, Neda Shamie, Richard S. Davidson, Thomas John, Edward J. Holland & Terry Kim. (2017) Surgical techniques and adjuvants for the management of primary and recurrent pterygia. Journal of Cataract and Refractive Surgery 43:3, pages 405-419.
Crossref
Crossref
Renata Kiri Mak, Tommy Chung Yan Chan, Marcus M Marcet, Bonnie Nga Kwan Choy, Jennifer Wei Huen Shum, Kendrick Co Shih, Ian Yat Hin Wong & Alex Lap Ki Ng. (2017) Use of anti-vascular endothelial growth factor in the management of pterygium. Acta Ophthalmologica 95:1, pages 20-27.
Crossref
Crossref
Sameh M Fouda. (2017) Evaluation of the Additive Effect of Bevacizumab Eye Drops to Mitomycin C in Primary Pterygium. Advances in Ophthalmology & Visual System 6:2.
Crossref
Crossref
Jun Seok LeeSang Won HaSung YuGwang Ja LeeYoung Jeung Park. (2017) Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium. Korean Journal of Ophthalmology 31:6, pages 469.
Crossref
Crossref
Sang Beom Han, Hyun Sun Jeon, Moosang Kim, Seung-Jun Lee, Hee Kyung Yang, Jeong-Min Hwang, Kwang Gi Kim, Joon Young Hyon & Won Ryang Wee. (2016) Risk Factors for Recurrence After Pterygium Surgery. Cornea 35:8, pages 1097-1103.
Crossref
Crossref
Qader Motarjemizadeh, Naser Samadi Aidenloo & Siamak Sepehri. (2015) A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. International Ophthalmology 36:1, pages 63-71.
Crossref
Crossref
Sang Yeop KimSang Jun Ko. (2016) The Effect of Inferior Conjunctival Transposition Flap for Recurrent Pterygium. Journal of the Korean Ophthalmological Society 57:12, pages 1866.
Crossref
Crossref
David Kuerten, Sandra Johnen, Nina Harmening, George Souteyrand, Peter Walter & Gabriele Thumann. (2015) Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model. Graefe's Archive for Clinical and Experimental Ophthalmology 253:7, pages 1061-1069.
Crossref
Crossref
Angel Nava-CastañedaIsabel Ulloa-OrozcoLilia Garnica-HayashiJoaquín Hernandez-OrgazMaria Carmen Jimenez-MartinezYonathan Garfias. (2015) Triple Subconjunctival Bevacizumab Injection for Early Corneal Recurrent Pterygium: One-Year Follow-Up. Journal of Ocular Pharmacology and Therapeutics 31:2, pages 106-113.
Crossref
Crossref
Tomás Rojas, Cristian Cumsille, Rodrigo Castillo, Daniel García, Álvaro Henríquez, Rodrigo Lacroix & Javier Corvalan. (2014) Uso de terapia antifactor de crecimiento vascular endotelial en patología corneal. Revista Mexicana de Oftalmología 88:3, pages 113-119.
Crossref
Crossref
Catherine Vumien Tonthat & Nick Di Girolamo. (2014) Nestin expression in pterygia: potential role in angiogenesis. British Journal of Ophthalmology 98:6, pages 801-807.
Crossref
Crossref
Koray Gumus, Sarper Karakucuk, G Ertugrul Mirza, Hulya Akgun, Hatice Arda & Ayse O Oner. (2014) Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. British Journal of Ophthalmology 98:6, pages 796-800.
Crossref
Crossref
Sezin Akca Bayar, Cem Kucukerdonmez, Ozlem Oner & Yonca A. Akova. (2013) Subconjunctival bevacizumab in the impending recurrent pterygia. International Ophthalmology 34:3, pages 541-547.
Crossref
Crossref
Ben J. Janson & Shameema Sikder. (2014) Surgical Management of Pterygium. The Ocular Surface 12:2, pages 112-119.
Crossref
Crossref
Qiongwen Hu, Yanbing Qiao, Xin Nie, Xiaocheng Cheng & Yongping Ma. (2014) Bevacizumab in the Treatment of Pterygium. Cornea 33:2, pages 154-160.
Crossref
Crossref
Julia Promesberger, Sharmila Kohli, Holger Busse & Constantin E. Uhlig. (2014) Pterygium Recurrence, Astigmatism and Visual Acuity following Bare-Sclera Excision and Conjunctival Autograft with or without Additional Phototherapeutic Keratectomy. Ophthalmic Research 51:1, pages 52-58.
Crossref
Crossref
Engin B. Ozgurhan, Alper Agca, Necip Kara, Kemal Yuksel, Ali Demircan & Ahmet Demirok. (2013) Topical Application of Bevacizumab as an Adjunct to Recurrent Pterygium Surgery. Cornea 32:6, pages 835-838.
Crossref
Crossref
Felix Bock, Kazuichi Maruyama, Birgit Regenfuss, Deniz Hos, Philipp Steven, Ludwig M. Heindl & Claus Cursiefen. (2013) Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Progress in Retinal and Eye Research 34, pages 89-124.
Crossref
Crossref
Michael Waisbourd, Eliya Levinger, David Varssano, Elad Moisseiev, Shiri Zayit-Soudri, Adiel Barak, Anat Loewenstein & Irina Barequet. (2013) High-Dose Topical Bevacizumab for Corneal Neovascularization. Pharmacology 92:5-6, pages 310-314.
Crossref
Crossref
Lokman Aslan, Murat Aslankurt, Adnan Aksoy, Murat Özdemir & Erdem Yüksel. (2013) Comparison of Wide Conjunctival Flap and Conjunctival Autografting Techniques in Pterygium Surgery. Journal of Ophthalmology 2013, pages 1-5.
Crossref
Crossref
Stephen C. Kaufman, Deborah S. Jacobs, W. Barry Lee, Sophie X. Deng, Mark I. Rosenblatt & Roni M. Shtein. (2013) Options and Adjuvants in Surgery for Pterygium. Ophthalmology 120:1, pages 201-208.
Crossref
Crossref
Oscar Rúa, Ignacio M. Larráyoz, María T. Barajas, Sara Velilla & Alfredo Martínez. (2012) Oral Doxycycline Reduces Pterygium Lesions; Results from a Double Blind, Randomized, Placebo Controlled Clinical Trial. PLoS ONE 7:12, pages e52696.
Crossref
Crossref
Sheng-Fu Cheng, Mohammad H. Dastjerdi, Giulio Ferrari, Andre Okanobo, Kraig S. Bower, Denise S. Ryan, Francisco Amparo, William Stevenson, Pedram Hamrah, Nambi Nallasamy & Reza Dana. (2012) Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization. American Journal of Ophthalmology 154:6, pages 940-948.e1.
Crossref
Crossref
Maha M. Shahin, Amal M. Elbendary & Mohamed M. Elwan. (2012) Intraoperative Subconjunctival Bevacizumab as an Adjunctive Treatment in Primary Pterygium: A Preliminary Report. Ophthalmic Surgery, Lasers and Imaging Retina 43:6, pages 459-466.
Crossref
Crossref
Jin-Hong Chang, Nitin K. Garg, Elisa Lunde, Kyu-Yeon Han, Sandeep Jain & Dimitri T. Azar. (2012) Corneal Neovascularization: An Anti-VEGF Therapy Review. Survey of Ophthalmology 57:5, pages 415-429.
Crossref
Crossref
Irit Bahar, Sonia N. Yeung, Ruti Sella & Allan Slomovic. (2012) Anterior segment uses of bevacizumab. Current Opinion in Ophthalmology 23:4, pages 303-316.
Crossref
Crossref
Hamid Hosseini, Mohammad H Nowroozzadeh, Ramin Salouti & Mahmood Nejabat. (2012) Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease. Cornea 31:3, pages 322-334.
Crossref
Crossref
Kaevalin Lekhanont, Thanikan Patarakittam, Prakairut Thongphiew, Olan Suwan-apichon & Prut Hanutsaha. (2012) Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium: A Pilot Study. Cornea 31:2, pages 155-161.
Crossref
Crossref
Orapin Enkvetchakul, Onsiri Thanathanee, Ram Rangsin, Kaevalin Lekhanont & Olan Suwan-apichon. (2011) A Randomized Controlled Trial of Intralesional Bevacizumab Injection on Primary Pterygium: Preliminary Results. Cornea 30:11, pages 1213-1218.
Crossref
Crossref
Achilleas Mandalos, Dimitrios Tsakpinis, Georgia Karayannopoulou, Ioannis Tsinopoulos, Georgios Karkavelas, Nikolaos Chalvatzis & Stavros Dimitrakos. (2010) The Effect of Subconjunctival Ranibizumab on Primary Pterygium: A Pilot Study. Cornea 29:12, pages 1373-1379.
Crossref
Crossref
Omar M. Kirat & Hassan A. Al-Dhibi. (2010) Regression of aggressive corneal vascularization after photodynamic therapy, subconjunctival Avastin injections and topical cyclosporin-A 1% drops: A case report. Saudi Journal of Ophthalmology 24:4, pages 151-154.
Crossref
Crossref
Mark C Gillies. (2010) Bevacizumab in ophthalmology: the controversy moves forward. Clinical & Experimental Ophthalmology 38:4, pages 333-334.
Crossref
Crossref